WTM = Wall Street. Technology. Medicine.
We're backing the next-generation of health care companies that will transform how care is delivered, accessed, and experienced. As a MD, I have seen first hand how broken our health care model is, led a team at Harvard Business School to transform it, and have a global network to source deals and find the best founders to invest in at the early stages. As a former investment banker at Citigroup and MBA MS from Cornell, I also have the business acumen to evaluate what will truly make an impact in today's complex health care industry.
My networks come from Harvard University, MIT, Harvard Medical School, Harvard Business School, Cornell University, Rice University, MD Anderson, Texas Children's Hospital, Methodist Hospital, Baylor College of Medicine, and the Texas Medical Center. I've built strong relationships with many of the best Boston, NYC, and Silicon Valley based VC firms including GV, a16z, .406 Ventures, Tau Ventures, Alley Corp, Bessemer Ventures, Flare Capital, KP Ventures, Intermountain Ventures, Harvard Management Corporation, Rice Management Corporation, and professionals at leading investment banks Citigroup, Leerink SVB, RBC Capital, Goldman Sachs, and more.
Current personal investments:
- Octant Bio (co investors Lux Capital, a16z, 8VC, SV Angel, Allen & Company, etc.)
- Bionaut Labs (co investors Khosla Ventures, Kapor Capital, Upfront Ventures, Revoution, and Bold Capital Partners)
- Health IQ (co investors include Andreessen Horowitz (a16z), CRV, Foundation Capital, Ribbit Capital. Investors in prior rounds include Menlo Ventures, Felicis Ventures, and First Round Capital.)
- Inside.com - founded by Jason Calacanis, better known as J-Cal. He led $30M exit, backed Uber, Robinhood, + 300 others. Inside.com is also backed by Sequoia Capital, Mark Cuban, and Jason Calacanis
- LP in Space Capital
- Investor in SpaceX
Expect to have a number of deals every quarter. We will select only the best companies to share with my LP base after my team has done initial DD. We receive a number of startups each week, but only after diligence do we offer these companies to my diversified and worldwide network of LPs.
